Talapatra J, Reddy M
Cancers (Basel). 2023; 15(7).
PMID: 37046804
PMC: 10093342.
DOI: 10.3390/cancers15072144.
Liu R, Shi P, Wang Z, Yuan C, Cui H
Front Oncol. 2021; 10:625332.
PMID: 33614505
PMC: 7886978.
DOI: 10.3389/fonc.2020.625332.
Huang M, Weiss W
Cold Spring Harb Perspect Med. 2013; 3(10):a014415.
PMID: 24086065
PMC: 3784814.
DOI: 10.1101/cshperspect.a014415.
Gillory L, Beierle E
Anticancer Agents Med Chem. 2011; 10(10):714-21.
PMID: 21269252
PMC: 3225183.
DOI: 10.2174/187152010794728684.
Beierle E
Front Biosci (Elite Ed). 2011; 3(2):421-33.
PMID: 21196322
PMC: 3171213.
DOI: 10.2741/e257.
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.
Murphy D, Buckley P, Bryan K, Das S, Alcock L, Foley N
PLoS One. 2009; 4(12):e8154.
PMID: 19997598
PMC: 2781550.
DOI: 10.1371/journal.pone.0008154.
Synthesis, characterization, and evaluation of a novel 99mTc(CO)3 pyrazolyl conjugate of a peptide nucleic acid sequence.
Xavier C, Giannini C, DallAngelo S, Gano L, Maiorana S, Alberto R
J Biol Inorg Chem. 2008; 13(8):1335-44.
PMID: 18777182
DOI: 10.1007/s00775-008-0419-y.
[Neuroblastoma].
Castel V, Canete A, Noguera R, Navarro S, Oltra S
Clin Transl Oncol. 2005; 7(3):133-45.
PMID: 15899223
DOI: 10.1007/BF02708748.
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A
Proc Natl Acad Sci U S A. 2005; 102(3):731-6.
PMID: 15644444
PMC: 545522.
DOI: 10.1073/pnas.0405495102.
KAP-2, a protein that binds to the H-box in a bean chalcone synthase promoter, is a novel plant transcription factor with sequence identity to the large subunit of human Ku autoantigen.
Lindsay W, McAlister F, Zhu Q, He X, Droge-Laser W, Hedrick S
Plant Mol Biol. 2002; 49(5):503-14.
PMID: 12090626
DOI: 10.1023/a:1015505316379.
Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T, Shirasawa H, Hishiki T, Enomoto H, Kouchi K, Ohtsuka Y
Jpn J Cancer Res. 1999; 89(12):1276-83.
PMID: 10081488
PMC: 5921738.
DOI: 10.1111/j.1349-7006.1998.tb00524.x.
myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome.
Flinn E, Busch C, Wright A
Mol Cell Biol. 1998; 18(10):5961-9.
PMID: 9742113
PMC: 109182.
DOI: 10.1128/MCB.18.10.5961.
AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3.
Santiago L, Erickson L, Hanin I
Neurochem Res. 1998; 23(5):743-50.
PMID: 9566614
DOI: 10.1023/a:1022459426566.
Modulation of N-myc expression alters the invasiveness of neuroblastoma.
Goodman L, Liu B, Thiele C, Schmidt M, Cohn S, Yamashiro J
Clin Exp Metastasis. 1997; 15(2):130-9.
PMID: 9062389
DOI: 10.1023/a:1018448710006.
Retinoids and the control of growth/death decisions in human neuroblastoma cell lines.
Melino G, Thiele C, Knight R, Piacentini M
J Neurooncol. 1997; 31(1-2):65-83.
PMID: 9049832
DOI: 10.1023/a:1005733430435.
The amplification of oligonucleotide themes in the evolution of the myc protooncogene family.
DOSKOCIL J
J Mol Evol. 1996; 42(5):512-24.
PMID: 8662003
DOI: 10.1007/BF02352281.
A polymorphic variant of human c-Myc: Asn11-->Ser.
Rothberg P, Otto Y
Mamm Genome. 1995; 6(3):209-11.
PMID: 7749231
DOI: 10.1007/BF00293016.
Human proto-oncogene N-myc encodes nuclear proteins that bind DNA.
Ramsay G, Stanton L, Schwab M, Bishop J
Mol Cell Biol. 1986; 6(12):4450-7.
PMID: 3796607
PMC: 367228.
DOI: 10.1128/mcb.6.12.4450-4457.1986.
Sequences of the 5' portion of the human c-sis gene: characterization of the transcriptional promoter and regulation of expression of the protein product by 5' untranslated mRNA sequences.
Ratner L, Thielan B, Collins T
Nucleic Acids Res. 1987; 15(15):6017-36.
PMID: 3627977
PMC: 306065.
DOI: 10.1093/nar/15.15.6017.
Amplification and expression of the N-myc gene in neuroblastoma.
Bartram C, Berthold F
Eur J Pediatr. 1987; 146(2):162-5.
PMID: 3569354
DOI: 10.1007/BF02343225.